Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Model of Hepatitis C Treatment as Anchor to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior

NCT03221309 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT03221309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03221309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Model of Hepatitis C Treatment as Anchor to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
Lead sponsor
University of Maryland, Baltimore
Phase
Observational
Overall status
Completed
Start date
May 1, 2017
Completion date
February 22, 2021
Enrollment
198 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

buprenorphine, hcv, prep